Viewing Study NCT01056393


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2025-12-27 @ 2:50 AM
Study NCT ID: NCT01056393
Status: COMPLETED
Last Update Posted: 2018-07-12
First Post: 2010-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Investigator-Sponsored Protocol - Continued Use of Ibalizumab
Sponsor: Kaiser Permanente
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module